Zhaoqi Xin

542 total citations
9 papers, 372 citations indexed

About

Zhaoqi Xin is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Zhaoqi Xin has authored 9 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Zhaoqi Xin's work include Ferroptosis and cancer prognosis (6 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (4 papers). Zhaoqi Xin is often cited by papers focused on Ferroptosis and cancer prognosis (6 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (4 papers). Zhaoqi Xin collaborates with scholars based in China and Saudi Arabia. Zhaoqi Xin's co-authors include Fangfang Lu, Xiaobo Xia, Tu Hu, Quanwei Zhou, Wen Yin, Xingjun Jiang, Caiping Ren, Jun Tan, Zhaoping Wu and Hecheng Zhu and has published in prestigious journals such as Journal of Cellular Physiology, Theranostics and Frontiers in Oncology.

In The Last Decade

Zhaoqi Xin

9 papers receiving 371 citations

Peers

Zhaoqi Xin

MB

PRM

IMMUN

CR

ONCOL

Tadeja Kuret Slovenia

Zhuo Gao China

Hidetaka Niizuma Japan

Xiaomeng Yi China

Ewa Kurzejamska Sweden

Qi Cai China

Jiang Xue China

Yeqing Zou China

Lena Succar Australia

Zhong‐Shi Lyu China

Tadeja Kuret Slovenia

Zhaoqi Xin

118 ×0.5

MB

108 ×1.1

PRM

124 ×1.3

IMMUN

57 ×0.6

CR

22 ×0.5

ONCOL

Citations per year, relative to Zhaoqi Xin Zhaoqi Xin (= 1×) peers Tadeja Kuret

Countries citing papers authored by Zhaoqi Xin

Since Specialization

Citations

This map shows the geographic impact of Zhaoqi Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaoqi Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaoqi Xin more than expected).

Fields of papers citing papers by Zhaoqi Xin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaoqi Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaoqi Xin. The network helps show where Zhaoqi Xin may publish in the future.

Co-authorship network of co-authors of Zhaoqi Xin

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaoqi Xin. A scholar is included among the top collaborators of Zhaoqi Xin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaoqi Xin. Zhaoqi Xin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Jiang, Zhipeng, Weidong Liu, Lei Wang, et al.. (2024). Integrated profiling identifies ferredoxin 1 as an immune-related biomarker of malignant phenotype in glioma. Heliyon. 10(5). e26976–e26976. 2 indexed citations

2.

Cao, Yudong, Hecheng Zhu, Weidong Liu, et al.. (2022). Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma. Frontiers in Genetics. 12. 758596–758596. 8 indexed citations

3.

Cao, Yudong, Hecheng Zhu, Jun Tan, et al.. (2021). Development of an Immune-Related LncRNA Prognostic Signature for Glioma. Frontiers in Genetics. 12. 678436–678436. 12 indexed citations

4.

Zhou, Quanwei, Hecheng Zhu, Zhaoqi Xin, et al.. (2021). Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma. Theranostics. 11(20). 9775–9790. 34 indexed citations

5.

Yin, Wen, Hecheng Zhu, Jun Tan, et al.. (2021). Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma. Cancer Cell International. 21(1). 276–276. 44 indexed citations

6.

Jiang, Zhipeng, Wen Yin, Hecheng Zhu, et al.. (2021). METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis. Cancer Cell International. 21(1). 383–383. 16 indexed citations

7.

Tan, Jun, Hecheng Zhu, Guihua Tang, et al.. (2021). Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients. Frontiers in Genetics. 12. 616507–616507. 11 indexed citations

8.

Yin, Wen, Xingjun Jiang, Jun Tan, et al.. (2020). Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma. Frontiers in Oncology. 10. 1409–1409. 53 indexed citations

9.

Lu, Fangfang, et al.. (2019). Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases. Journal of Cellular Physiology. 235(4). 3207–3221. 192 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact